Marker Therapeutics, Inc. (MRKR)

Marker Therapeutics Revenue

Marker Therapeutics had revenue of $1.93M in the quarter ending September 30, 2024, with 647.66% growth. This brings the company's revenue in the last twelve months to $5.40M, up 79.04% year-over-year. In the year 2023, Marker Therapeutics had annual revenue of $3.31M, down -5.76%.

• Revenue (ttm): $5.40M
• Revenue Growth: +79.04%
• P/S Ratio: 6.27
• Revenue / Employee: $674,481
• Employees: 8
• Market Cap: 33.91M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	3.31M	-202.41K	-5.76%
Dec 31, 2022	3.51M	2.27M	182.96%
Dec 31, 2021	1.24M	774.93K	166.01%
Dec 31, 2020	466.79K	253.59K	118.95%
Dec 31, 2019	213.19K	7.20K	3.50%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.